ASPIRA WOMEN'S HEALTH INC (AWH) Stock Price, Forecast & Analysis
NASDAQ:AWH • US04537Y2081
AWH Key Statistics, Chart & Performance
The current stock price of AWH is 0.082 USD. In the past month the price decreased by -30.51%. In the past year, price decreased by -97.65%.
AWH Technical Analysis
AWH Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AWH. Both the profitability and financial health of AWH have multiple concerns.
AWH Financial Highlights
Over the last trailing twelve months AWH reported a non-GAAP Earnings per Share(EPS) of -0.99. The EPS increased by 44.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -238.46% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AWH Forecast & Estimates
5 analysts have analysed AWH and the average price target is 5.61 USD. This implies a price increase of 6741.46% is expected in the next year compared to the current price of 0.082.
For the next year, analysts expect an EPS growth of 46.73% and a revenue growth 79.1% for AWH
AWH Ownership
AWH Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.57 | 196.997B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.98 | 177.835B | ||
| SYK | STRYKER CORP | 24.57 | 144.295B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.67 | 113.125B | ||
| BDX | BECTON DICKINSON AND CO | 11.58 | 52.047B | ||
| IDXX | IDEXX LABORATORIES INC | 42.68 | 50.697B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.22 | 45.832B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.33 | 37.804B | ||
| RMD | RESMED INC | 20.99 | 37.718B | ||
| DXCM | DEXCOM INC | 28.44 | 28.394B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AWH
Company Profile
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. The company is headquartered in Austin, Texas and currently employs 66 full-time employees. The company went IPO on 2000-09-29. The firm's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their initial clinical assessment indicates the mass is indeterminate or benign. The Ova1Plus is a reflex process of two tests, Ova1 and Overa, to assess the risk of ovarian malignancy in women with an adnexal mass planned for surgery. Its product pipelines are OVAinform and ENDOinform. OVAinform is a test that combines serum proteins, clinical data (metadata), and miRNA for assessing the risk of ovarian cancer in women with an adnexal mass. ENDOinform is a test program that combines serum proteins, clinical data (metadata), and miRNA for the identification of endometriosis.
Company Info
ASPIRA WOMEN'S HEALTH INC
12117 Bee Caves Road Building Three, Suite 100
Austin TEXAS 78738 US
CEO: Valerie B. Palmieri
Employees: 64
Phone: 15125190400
ASPIRA WOMEN'S HEALTH INC / AWH FAQ
What does AWH do?
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. The company is headquartered in Austin, Texas and currently employs 66 full-time employees. The company went IPO on 2000-09-29. The firm's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their initial clinical assessment indicates the mass is indeterminate or benign. The Ova1Plus is a reflex process of two tests, Ova1 and Overa, to assess the risk of ovarian malignancy in women with an adnexal mass planned for surgery. Its product pipelines are OVAinform and ENDOinform. OVAinform is a test that combines serum proteins, clinical data (metadata), and miRNA for assessing the risk of ovarian cancer in women with an adnexal mass. ENDOinform is a test program that combines serum proteins, clinical data (metadata), and miRNA for the identification of endometriosis.
What is the stock price of ASPIRA WOMEN'S HEALTH INC today?
The current stock price of AWH is 0.082 USD. The price decreased by -12.49% in the last trading session.
Does AWH stock pay dividends?
AWH does not pay a dividend.
What is the ChartMill rating of ASPIRA WOMEN'S HEALTH INC stock?
AWH has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the Price/Earnings (PE) ratio of ASPIRA WOMEN'S HEALTH INC (AWH)?
ASPIRA WOMEN'S HEALTH INC (AWH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.99).
What is the ownership structure of ASPIRA WOMEN'S HEALTH INC (AWH)?
You can find the ownership structure of ASPIRA WOMEN'S HEALTH INC (AWH) on the Ownership tab.